How Does Cost-Effectiveness Analysis Inform Health Care Decisions?

Abstract

Cost-effectiveness analysis (CEA) provides a formal assessment of trade-offs involving benefits, harms, and costs inherent in alternative options. CEA has been increasingly used to inform public and private organizations' reimbursement decisions, benefit designs, and price negotiations worldwide. Despite the lack of centralized efforts to promote CEA in the United States, the demand for CEA is growing. This article briefly reviews the history of CEA in the United States, highlights advances in practice guidelines, and discusses CEA's ethical challenges. It also offers a way forward to inform health care decisions.To claim one AMA PRA Category 1 Credit TM for the CME activity associated with this article, you must do the following: (1) read this article in its entirety, (2) answer at least 80 percent of the quiz questions correctly, and (3) complete an evaluation. The quiz, evaluation, and form for claiming AMA PRA Category 1 Credit TM are available through the AMA Ed Hub TM .

Extracapsular Dissection Versus Superficial Parotidectomy: A Systematic Review and Meta-Analysis of Perioperative Efficiency

“…By addressing this knowledge gap, our study provides important insight into the comparison of ECD and SP, enabling more informed decision-making that balances clinical effectiveness with procedural efficiency and supports thoughtful use of healthcare resources. 37,38 Our results indicate that ECD requires significantly less operative time and anesthesia time compared to SP. The primary procedural difference between these 2 techniques lies in the need for formal FN dissection in SP, which likely accounts for the increased time requirement.…”

Introducing an Expanded Value Framework in Health Technology Assessment of Vaccines

“…Indirect savings may also arise through herd protection. Overall, this value element reflects the balance between the upfront investment required for vaccination and the downstream cost savings and health benefits it generates; this information is essential for sustainable resource allocation in immunization programs [ 20 ]. The fact that the impact of budget can be considered relatively modest for vaccines can be interpreted as an additional value to net costs and QALYs.…”

“…CEA integrates clinical and economic outcomes using QALYs, DALYs, and ICERs, supported by data on vaccine efficacy, safety, coverage, and disease severity [ 5 , 20 , 26 ]. In general, CEAs translate direct and indirect benefits, including reduced healthcare use, herd protection, and avoided long-term complications, into comparable units of value.…”

Demographic Insights into Migraine Prevalence and a Cost-Effective Analysis of Various Prophylactic Medications

“…By evaluating the cost-effectiveness of various therapies, governments, healthcare professionals, and patients can make informed decisions about which interventions to pursue and which to avoid, ultimately enhancing the overall health of a community. Finally, costeffectiveness analysis can aid in ensuring that healthcare resources are used efficiently 24 .…”